Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: a clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs. (Q52608609)
Jump to navigation
Jump to search
scientific article published on 2 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: a clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs. |
scientific article published on 2 March 2011 |
Statements
Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: a clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs. (English)
Roberto Bergamaschi
Mario Rotondi
Francesca Stufano
Maria Stefania Lagonigro
Luigi La Manna
Francesca Zerbini
Stefania Ghilotti
Maria Teresa Pagliari
Francesca Coperchini
Flavia Magri
Antonio Oliviero
Luca Chiovato
2 March 2011
234
1-2
161-164